Results 171 to 180 of about 40,526 (207)

Standard prophylactic versus intermediate dose enoxaparin in adults with severe COVID‐19: A multi‐center, open‐label, randomized controlled trial

Journal of Thrombosis and Haemostasis, 2021
Sanjana Dayal, Faha, Grerk Sutamtewagul, Steven Lentz   +2 more
exaly  

Enoxaparin

Reactions Weekly, 1992
openaire   +1 more source

Enoxaparin sodium

Reactions Weekly, 2020
openaire   +2 more sources

Enoxaparin sodium

Reactions Weekly, 2022
  +4 more sources

Enoxaparin sodium

Reactions Weekly, 2017
  +4 more sources

Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial

Lancet, The, 2008
Bengt I Eriksson
exaly  

Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial

Lancet, The, 2010
Alexander S Gallus
exaly  

Scientific considerations in the review and approval of generic enoxaparin in the United States

Nature Biotechnology, 2013
Robert A Lionberger, Daniela Verthelyi
exaly  

The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison

Lancet, The, 2007
Christopher F Bladin
exaly  

Enoxaparin sodium

Reactions Weekly, 2011
openaire   +2 more sources